Evoke Pharma Cash from Financing (TTM) Analysis

Evoke Pharma Inc (EVOK)

0.47 +0.03 (+7.80%) USD | NASDAQ | Apr 26, 16:00

0.47 0.00 (0.00%) After-Hours: 18:34

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2012. Upgrade now.

Date	Value
December 31, 2023	-0.1193M
September 30, 2023	0.00
June 30, 2023	0.00
March 31, 2023	7.124M
December 31, 2022	7.295M
September 30, 2022	7.295M
June 30, 2022	7.608M
March 31, 2022	0.5301M
December 31, 2021	13.43M
September 30, 2021	16.93M
June 30, 2021	16.72M
March 31, 2021	22.08M
December 31, 2020	9.035M
September 30, 2020	5.842M
June 30, 2020	5.865M
March 31, 2020	5.492M
December 31, 2019	6.107M
September 30, 2019	5.800M
June 30, 2019	6.863M
March 31, 2019	4.710M
December 31, 2018	4.618M
September 30, 2018	4.618M
June 30, 2018	3.488M

Date	Value
March 31, 2018	0.599M
December 31, 2017	7.389M
September 30, 2017	7.386M
June 30, 2017	16.00M
March 31, 2017	16.26M
December 31, 2016	9.024M
September 30, 2016	9.432M
June 30, 2016	4.123M
March 31, 2016	4.598M
December 31, 2015	5.031M
September 30, 2015	9.126M
June 30, 2015	5.809M
March 31, 2015	2.352M
December 31, 2014	1.460M
September 30, 2014	-0.6919M
June 30, 2014	22.23M
March 31, 2014	24.76M
December 31, 2013	27.12M
September 30, 2013	24.77M
June 30, 2013	2.811M
March 31, 2013	3.00M
December 31, 2012	1.00M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.1193M

Minimum

Dec 2023

22.08M

Maximum

Mar 2021

7.573M

Average

6.863M

Median

Jun 2019

Cash from Financing (TTM) Benchmarks